Despite this, chronically lowered insulin/IGF signaling can improve metabolic, synaptic, and cognitive defects in rodent and Drosophila models of several neurodegenerative diseases [30–36], leading to what has become known as the “insulin paradox” [37]. The gene discussed is INS; the disease is neurodegenerative disease.